SCHEMBL5017072

SCHEMBL5017072

O=C(OC(COCc1ccccc1)COCc1ccccc1)C1CCCCN1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.47
HTR2B P41595 1/20 0.47
CTSC P53634 2/20 0.44
TSHR P16473 3/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
APOBEC3A P31941 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40
SLC6A3 Q01959 4/20 0.40
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 1/20 0.40
DHFR P00374 1/20 0.40
POLB P06746 1/20 0.40
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3676417 1.00 HTR2C (0.47) HTR2CHTR2BCTSCTSHRCYP3A4
SCHEMBL16586274 0.88 HTR2C (0.46) HTR2CHTR2BCTSCTSHRCYP3A4
SCHEMBL16586276 0.88 HTR2C (0.46) HTR2CHTR2BCTSCTSHRCYP3A4
SCHEMBL16586278 0.88 HTR2C (0.46) HTR2CHTR2BCTSCTSHRCYP3A4
SCHEMBL3674851 0.82 FKBP1A (0.47) HTR2CHTR2BCTSCTSHRCYP3A4
SCHEMBL7220110 0.81 FKBP1A (0.53) HTR2CHTR2BCTSCTSHRCYP3A4
SCHEMBL630942 0.80 TSHR (0.61) HTR2CHTR2BTSHRPOLBALDH1A1
SCHEMBL6727374 0.80 TSHR (0.61) HTR2CHTR2BTSHRPOLBALDH1A1
SCHEMBL31364184 0.80 CTSC (0.53) HTR2CHTR2BCTSCTSHRCYP3A4
Hydrochloric Acid SCHEMBL630943 0.79 TSHR (0.64) HTR2CHTR2BTSHRSLC6A3SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1227859-B1 NEUROPHILIN LIGANDS FOR TREATING OCULAR CONDITIONS ALCON INC (CH) 2006-08-09 EP claimed
EP-1138673-B1 Novel carbamates and ureas as modifiers of multi-drug resistance VERTEX PHARMA (US) 2008-08-06 EP disclosed
EP-1666053-A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors Vertex Pharmceuticals Incorporated (US) 2006-06-07 EP disclosed
EP-0754176-B1 NOVEL CARBAMATES AND UREAS AS MODIFIERS OF MULTI-DRUG RESISTANCE VERTEX PHARMA (US) 2001-12-05 EP disclosed
EP-1138673-A2 Novel carbamates and ureas as modifiers of multi-drug resistance Vertex Pharmaceuticals Incorporated (US) 2001-10-04 EP disclosed
US-5780484-A Methods for stimulating neurite growth with piperidine compounds VERTEX PHARMACEUTICALS INCORPORATED (US) 1998-07-14 US disclosed
US-5744485-A INCREASE SENSITIVITY OF CELLS; CANCER VERTEX PHARMACEUTICALS INCORPORATED (US) 1998-04-28 US disclosed